alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EX-10.7



 Exhibit 10.7 

March 22, 2018 
 To: Shanghai Cango Investment and
Management Consultation Service Co., Ltd. (the “VIE Entity”) 
 To Whom It May Concern: 

To ensure the cash flow requirements of the VIE Entity’s operations are met and/or to set off any loss accrued during such operations, the undersigned,
Cango Inc. (the “Company”), is obligated and hereby undertakes to provide unlimited financial support to the VIE Entity, to the extent permissible under the applicable laws and regulations of the PRC and the Cayman Islands whether
or not any such operational loss is actually incurred. The form of financial support shall include, but not limited to, extension of cash, entrusted loans and borrowings. The Company will not request repayment of the loans or borrowings if the VIE
Entity or its shareholders do not have sufficient funds or are unable to repay. 
 The undersigned agrees and acknowledges such undertaking shall be
irrevocable and continuously valid from the date hereof until the date on which all of the equity interests of the VIE Entity have been acquired directly or indirectly by the Company or its designated representative (individual or legal person).

 Please confirm receipt of this letter by returning a signed copy of this letter to the undersigned. 

 

			
	Cango Inc.
	
	 /s/ Xiaojun Zhang

	Name:	 	Xiaojun Zhang
	Title:	 	Authorized Signatory
Turk K. CAZIMERO, petitioner, v. UNITED STATES.

No. 17-9006.

Supreme Court of the United States

June 18, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
Joseph P. CARSON, petitioner, v. MERIT SYSTEMS PROTECTION BOARD.

No. 17-1434.

Supreme Court of the United States

June 11, 2018.

Motion of petitioner to defer consideration of the petition for writ of certiorari denied. Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit denied.

Justice KAGAN took no part in the consideration or decision of this motion and this petition.
Exhibit 10.6


 


关于《独家业务合作协议》、《独家购买权合同》、《股权质押协议》、《按期申报协议》、《授权委托书》之终止协议


 


本终止协议(“本协议”)由以下双方于2018年6月19日在北京海淀签署:


 


		(1)	吴江鲈乡信息技术咨询有限公司(下称“鲈乡信息”),一家中国设立的外商独资企业,地址为吴江经济技术开发区云梨路1688号;



 


		(2)	北京有教科技有限公司(下称“北京有教”),一家依照中国法律设立和存在的公司,地址为北京市密云区太师屯镇永安街镇政府办公楼415-2351;



 


鉴于:


 


		(1)	2018年5月10日,各方签署了《独家业务合作协议》、《独家购买权合同》、《股权质押协议》、《按期申报协议》、《授权委托书》等相关文件(“VIE协议”)。



 


		(2)	各方拟终止投资协议的履行。



 


经协商一致,各方同意签署本协议:


 


		1.	VIE协议终止



 


		1.1	VIE协议全部终止;



 


		1.2	各方不再对对方负有任何权力和义务,未执行的条款不再执行。



 


		2.	协议生效



 


本协议自签署之日起,对签署各方产生约束力.


 


		3.	保密



 


		3.1	未经对方书面许可,任何一方不得向第三方(有关法律、法规、政府部门、证券交易所或其它监管机构要求和甲乙双方的法律、会计、商业及其它顾问、授权雇员除外)泄露本协议的条款的任何内容以及本协议的签订及履行情况,以及通过签订和履行本协议而获知的对方及对方关联公司的任何信息。但是为了境外交易之目的,将本协议披露给本次境外交易的其他投资者除外。



 


		3.2	本协议有效期内及终止后2年内,本保密条款仍具有法律效力。



 






     


     


    

 


		4.	违约责任



 


		4.1	违约赔偿。任何一方违反本协议的约定,在收到守约方通知后30个工作日内违约状况仍未改变的,违约方应当赔偿因其违约行为给守约方造成的一切损失、损害、责任、成本或支出,包括但不限于合理的诉讼/仲裁费用、公证费和律师费。



 


		4.2	本协议规定的权利和救济是累积的,并不排斥法律规定的其他权利或者救济。本协议所规定各方的义务是特殊、特定、且非一般性的,因此在任何一方违约时,损害赔偿如不足以弥补损失,非违约方有权要求违约方实际履行。



 


		5.	不可抗力



 


		5.1	不可抗力是指协议各方不能合理控制、不可预见或即使预见亦无法避免的事件,该事件妨碍、影响或延误任何一方根据协议履行其全部或部分义务。该事件包括但不限于政府行为、自然灾害、战争或任何其它类似事件。



 


		5.2	出现不可抗力事件时,知情方应及时、充分地向对方以书面形式发通知,并告知对方该类事件对本协议可能产生的影响,并应当在合理期限内提供相关证明。



 


		5.3	由于以上所述不可抗力事件致使协议的部分或全部不能履行或延迟履行,则协议各方于彼此间不承担任何违约责任。



 


		6.	适用法律及争议解决



 


		6.1	以中华人民共和国法律为本协议的适用法律。



 


		6.2	如果协议各方因本协议或本协议的任何条款的解释或执行而发生争议、索赔或争端(以下总称“争议”),协议各方应一秉善意,及时进行友好协商,以尽量合乎双方意图和目的的方式来解决争议。如果各方无法在三十天内解决此种争议,应将该争端提交仲裁,该种仲裁应当提交北京仲裁委员会根据其现行有效的仲裁规则进行裁决,仲裁裁决具有最终和排它的约束力。



 


		7.	其他



 


		7.1	本协议由各方签字方为有效。



 


		7.2	本协议的任何一方未能及时行使本协议项下的权利不应被视为放弃该权利,也不影响该方在将来行使该权利。



 


		7.3	如果本协议中的任何条款无论因何种原因完全或部分无效或不具有执行力,或违反任何适用的法律,则该条款被视为删除,但本协议的其余条款仍应有效并且有约束力。



 


		7.4	本协议未尽事宜由协议各方友好协商后,以书面形式加以补充,该补充协议与本协议具有同等法律效力。



 


		7.5	本协议附件为本协议不可分割的一部分,与本协议有同等法律效力。



 


		7.6	本协议一式伍份,协议各方各持壹份,具有同等法律效力。



 


(本行以下无正文)


 


 




    2


     


    

 


本页无正文,为《终止协议》之签字页


 


	吴江鲈乡信息技术咨询有限公司	 
	 	 
	授权代表:	/s/
    Long     Yi	 
	 	 	 
	北京有教科技有限公司
	 	 	 
	授权代表:	/s/
    李爱珍	 




 






    3
# C_2011173EN.01000903.xml

| 11.6.2011 | EN | Official Journal of the European Union | C 173/9 |
| --- | --- | --- | --- |

11.6.2011

EN

Official Journal of the European Union

C 173/9

---

Order of the President of the Eighth Chamber of the Court of 28 February 2011 — European Commission v Republic of Estonia

(Case C-407/10) (1)

1

2011/C 173/20

Language of the case: Estonian

The President of the Eighth Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 274, 9.10.2010.

1

---
Maurice Odell BROWN, petitioner, v. UNITED STATES.

No. 17-5624.

Supreme Court of the United States

Oct. 2, 2017.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
EXHIBIT 32

Certification of CEO and CFO Pursuant to
18 U.S.C. Section 1350,
as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of Aztar Corporation (the "Company") for the quarterly period ended October 2, 2003 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Paul E. Rubeli, as Chief Executive Officer of the Company, and Robert M. Haddock, as Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:
     (1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
     (2)   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

|PAUL E. RUBELI    |                                                  
|----------------- | -------------------------------------------------
|Name:             | Paul E. Rubeli                                   
|Title:            | Chairman of the Board and
Chief Executive Officer
|Date:             | November 4, 2003                                 
|                  |                                                  
|                  |                                                  
|                  |                                                  
|                  |                                                  
|                  |                                                  
|ROBERT M. HADDOCK |                                                  
|Name:             | Robert M. Haddock                                
|Title:            | President and
Chief Financial Officer            
|Date:             | November 4, 2003                                 
|                  |                                                  

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Aztar Corporation and will be retained by Aztar Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel; Synthesis and Distribution of Drugs of Abuse and Related Compounds.                    

*Date:*                         May 9, 2022.                    

*Time:*                         1:00 p.m. to 2:00 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Institutes of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Marisa Srivareerat, Ph.D., Scientific Review Officer, Scientific Review Branch, Office of Extramural Policy, National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 435-1258,                         *marisa.srivareerat@nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)

Dated: April 11, 2022.

Tyeshia M. Roberson-Curtis,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2022-08086 Filed 4-14-22; 8:45 am]

BILLING CODE 4140-01-P
# C_2014175EN.01003501.xml

| 10.6.2014 | EN | Official Journal of the European Union | C 175/35 |
| --- | --- | --- | --- |

10.6.2014

EN

Official Journal of the European Union

C 175/35

---

Judgment of the General Court of 10 April 2014 — Evropaïki Dynamiki v Commission

(Case T-340/09) (1)

1

((Public service contracts - Call for tenders by the Publications Office - Assistance in the provision of publishing and communication services in connection with the CORDIS website - Rejection of a tenderer’s offers and decision to award the contracts to other tenderers - Classification of the tenderer’s offer - Obligation to state reasons - Article 148(1) and (3) of the Implementing Rules - Manifest error of assessment - Non-contractual liability))

2014/C 175/45

Language of the case: English

Parties

Parties

Applicant: Evropaïki Dynamiki — Proigmena Systimata Tilepikoinonion Pliroforikis kai Tilematikis AE (Athens, (Greece) (represented by: N. Korogiannakis and M. Dermitzakis, lawyers)

Applicant:

Defendant: European Commission (represented by: represented initially by S. Delaude and N. Bambara, and subsequently by S. Delaude, acting as Agents, assisted by C. Erkelens, lawyer)

Defendant:

Re:

Re:

Application, first, for annulment of the decision of the Office for Official Publications of the European Communities, notified to the applicant by letter of 9 June 2009, not to select its tenders submitted in response to call for tender No 10017 (CORDIS) in relation to Lot B, entitled ‘Editorial and publishing services’, and Lot C, entitled ‘Provision of New Digital Information Services’, respectively, and to place its tender, submitted in response to that call for tenders in third position for Lot E, entitled ‘Development and Maintenance of Core Services’, and, second, for damages.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1) | Dismisses the action; |
| --- | --- |

1)

Dismisses the action;

| 2) | Orders Evropaïki Dynamiki — Proigmena Systimata Tilepikoinonion Pliroforikis kai Tilematikis AE to bear 90% of its own costs and 90% of the costs incurred by the European Commission and orders the Commission to bear 10% of its own costs and 10% of the costs incurred by Evropaïki Dynamiki — Proigmena Systimata Tilepikoinonion Pliroforikis kai Tilematikis. |
| --- | --- |

2)

Orders Evropaïki Dynamiki — Proigmena Systimata Tilepikoinonion Pliroforikis kai Tilematikis AE to bear 90% of its own costs and 90% of the costs incurred by the European Commission and orders the Commission to bear 10% of its own costs and 10% of the costs incurred by Evropaïki Dynamiki — Proigmena Systimata Tilepikoinonion Pliroforikis kai Tilematikis.

---

(1)  OJ C 267, 7. 11. 2009.

1

---
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1997             DEC-31-1997
<PERIOD-START>                             JUL-01-1997             JAN-01-1997
<PERIOD-END>                               SEP-30-1997             SEP-30-1997
<CASH>                                               0                 3856584
<SECURITIES>                                         0                       0
<RECEIVABLES>                                        0                31883404
<ALLOWANCES>                                         0                 2172000
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                     0                39186542
<PP&E>                                               0                35847793
<DEPRECIATION>                                       0                13010236
<TOTAL-ASSETS>                                       0                93916268
<CURRENT-LIABILITIES>                                0                32389239
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                             0                   91076
<OTHER-SE>                                           0                34240238
<TOTAL-LIABILITY-AND-EQUITY>                         0                93916268
<SALES>                                       42640666               122383289
<TOTAL-REVENUES>                              42640666               122383289
<CGS>                                         19997223                58772879
<TOTAL-COSTS>                                 35866310               104611864
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                              695092                 2129336
<INCOME-PRETAX>                                6325196                15987858
<INCOME-TAX>                                   2520153                 6392888
<INCOME-CONTINUING>                                  0                       0
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                   3805043                 9594970
<EPS-PRIMARY>                                      .41                    1.03
<EPS-DILUTED>                                      .41                    1.03
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE>                                                     5
<LEGEND>
Exhibit 27     -      Financial Data Schedule

THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF INPRISE CORPORATION AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS
</LEGEND>
<MULTIPLIER>                                              1,000

<S>                                                 <C>
<PERIOD-TYPE>                                             9-MOS
<FISCAL-YEAR-END>                                   DEC-31-2000
<PERIOD-START>                                      JAN-01-2000
<PERIOD-END>                                        SEP-30-2000
<CASH>                                                  214,415
<SECURITIES>                                             36,272
<RECEIVABLES>                                            50,933
<ALLOWANCES>                                             (3,171)
<INVENTORY>                                                 255
<CURRENT-ASSETS>                                        298,221
<PP&E>                                                  115,243
<DEPRECIATION>                                          (94,335)
<TOTAL-ASSETS>                                          325,463
<CURRENT-LIABILITIES>                                    73,757
<BONDS>                                                       0
<PREFERRED-MANDATORY>                                         0
<PREFERRED>                                                   0
<COMMON>                                                    615
<OTHER-SE>                                              231,313
<TOTAL-LIABILITY-AND-EQUITY>                            325,463
<SALES>                                                 120,700
<TOTAL-REVENUES>                                        140,773
<CGS>                                                     9,431
<TOTAL-COSTS>                                            24,191
<OTHER-EXPENSES>                                        112,477
<LOSS-PROVISION>                                            494
<INTEREST-EXPENSE>                                          744
<INCOME-PRETAX>                                          16,190
<INCOME-TAX>                                              3,891
<INCOME-CONTINUING>                                      12,300
<DISCONTINUED>                                                0
<EXTRAORDINARY>                                               0
<CHANGES>                                                     0
<NET-INCOME>                                             12,300
<EPS-BASIC>                                                0.19
<EPS-DILUTED>                                              0.18


</TABLE>
<Page>

                                                                   EXHIBIT 31.01

                     RULE 13a-14(a)/15d-14(a) CERTIFICATIONS

I, Robert M. Alderman, certify that:

1. I have reviewed this report on Form 10-Q of John W. Henry & Co./Millburn
L.P.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

   a) Designed such disclosure controls and procedures, or caused such
   disclosure controls and procedures to be designed under our supervision, to
   ensure that material information relating to the registrant, including its
   consolidated subsidiaries, is made known to us by others within those
   entities, particularly during the period in which this report is being
   prepared;

   b) Evaluated the effectiveness of the registrant's disclosure controls and
   procedures and presented in this report our conclusions about the
   effectiveness of the disclosure controls and procedures, as of the end of the
   period covered by this report based on such evaluation;

   c) Disclosed in this report any change in the registrant's internal control
   over financial reporting that occurred during the registrant's most recent
   fiscal quarter that has materially affected, or is reasonably likely to
   materially affect, the registrant's internal control over financial
   reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent functions):

   a) All significant deficiencies and material weaknesses in the design or
   operation of internal control over financial reporting which are reasonably
   likely to adversely affect the registrant's ability to record, process,
   summarize and report financial information; and

   b) Any fraud, whether or not material, that involves management or other
   employees who have a significant role in the registrant's internal control
   over financial reporting.


Date: November 15, 2004


By /s/ ROBERT M. ALDERMAN
   ----------------------
Robert M. Alderman
Chief Executive Officer, President and Manager
(Principal Executive Officer)

                                       15
EMPLOYMENT AGREEMENT


 

 

 

 

EMPLOYMENT AGREEMENT EXTENSION

 

 

EMPLOYMENT AGREEMENT EXTENSION made effective as of this 1st day of June 2018 (“Effective Date”) by and between MAGELLAN GOLD CORPORATION (“Magellan”), a Nevada Corporation with an office address of 2010A Harbison Drive #312, Vacaville, California 95687 and W. PIERCE CARSON (“Carson”), an individual with an address of P.O. Box 831, Cedar Crest, New Mexico 87008.  

 

 

WHEREAS, Magellan and Carson entered into an Employment Agreement effective June 1, 2016 (the “Agreement”); and 

 

WHEREAS, Magellan and Carson would like to extend the Term (as defined in the Agreement) of the Agreement. 

 

WITNESSETH:

 

In consideration of the mutual covenants and agreements herein contained, Magellan and Carson hereby agree as follows:

 

The Term of Carson’s employment is extended through and including May 31, 2019, unless earlier terminated as provided for in the Agreement.   

 

All other terms and provisions contained in the Agreement remain in full force and effect. 

 

            IN WITNESS WHEREOF, Magellan has caused this Agreement to be executed by its officer thereunto duly authorized, and Carson has executed this Agreement as of the date set forth below.          

 

 

MAGELLAN GOLD CORPORATION

 

/s/ John C. Power

John C. Power, DirectorJune 1, 2018 

  

 

 

W. PIERCE CARSON

 

/s/ W. Pierce Carson

W. Pierce CarsonJune 1, 2018 


1